Down-regulation of SREBP-1 and/or FASN using sequence-specific miRNAs (miRNA-185 and 342 [26]) or selective small compounds (IPI-9119 [32], orlistat [33], and fatostatin [34]) has been reported to inhibit cell growth, survival and progression in cancers. Here, FASN is linked to cancer.